3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
87
Carcinoma, Non-Small-Cell Lung
78
Multiple Myeloma
72
Prostatic Neoplasms
66
Neoplasms
47
Lymphoma
43
Leukemia, Myeloid, Acute
42
Neoplasm Metastasis
38
Melanoma
38
Lymphoma, Non-Hodgkin
33
Squamous Cell Carcinoma of Head and Neck
32
Ovarian Neoplasms
32
Lung Neoplasms
32
Hematologic Neoplasms
29
Leukemia, Lymphocytic, Chronic, B-Cell
28
Colorectal Neoplasms
27
Triple Negative Breast Neoplasms
23
Hodgkin Disease
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Myelodysplastic Syndromes
21
Sarcoma
20
Pancreatic Neoplasms
20
Fallopian Tube Neoplasms
20
Carcinoma, Renal Cell
20
Urinary Bladder Neoplasms
17
Lymphoma, Follicular
17
Leukemia
17
Head and Neck Neoplasms
17
Glioma
17
Recurrence
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Cachexia
×
90 days
×
Clear all
NCT05546476
2026-06-03
PROACC-1
Pfizer
Phase 2
Completed
187 enrolled
24 charts